Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback